Author:
PEREIRA Ericson,MOYSES Samuel Jorge,IGNÁCIO Sérgio Aparecido,MENDES Daniel Komarchewski,SILVA Diego Sgarbi D. A.,CARNEIRO Everdan,HARDY Ana Maria Trindade Grégio,ROSA Edvaldo Antônio Ribeiro,BETTEGA Patrícia Vida Cassi,JOHANN Aline Cristina Batista Rodrigues
Abstract
Abstract
Background
To verify the prevalence and profile of users and non-users of anabolic steroid (AS) among resistance training practitioners.
Methods
An observational, cross-sectional survey was performed in 100 gyms in Curitiba city, involving 5773 individuals and self-administered questionnaires. The chi-square and z-tests of proportions were used for comparison between the groups (p < 0.05).
Results
83.2% did not use, 9.1% formerly used, 3.4% currently used, and 4.3% intended used AS. The prevalence of former or current AS users was 16.9 and 6.5% among men and women, respectively. The prevalence ratios were as follows: 1) 2.6 male users for each woman; 2) 3.3 individuals aged 30–44 years and 2.8 individuals aged 18–29 years for each individual aged over 45 years. Beginners were not interested in using AS, but individuals who had trained longer had higher prevalence of AS use.
Conclusions
The gym environment encouraged the use of AS owing to aesthetic appeal. Thus, suggesting the need for actions to prevent abusive use of AS considering the practitioners profile (practitioners were young, university and single).
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference39 articles.
1. Llewellyn W. Anabolics. Molecular Nutrition. 9th ed. Florida; 2009.
2. Ramasamy R, Wilken N, Scovell JM, Lipshultz LI. Effect of testosterone supplementation on symptoms in men with hypogonadism. Eur Urol. 2015;67:176.
3. Giri D, Patil P, Blair J, Dharmaraj P, Ramakrishnan R, Das U, et al. Testosterone therapy improves the first year height velocity in adolescent boys with constitutional delay of growth and puberty. Int J Endocrinol Metab. 2017;15:1–4.
4. Van Amsterdam J, Opperhuizen A, Hartgens F. Adverse health effects of anabolic-androgenic steroids. Regul Toxicol Pharmacol. 2010;57:117–23.
5. Petersson A, Bengtsson J, Voltaire-Carlsson A, Thiblin I. Substance abusers motives for using anabolic androgenic steroids. Drug Alcohol Depend. 2010;1:170–2.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献